
Emily M. Le
Examiner (ID: 5908)
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1648, 1734, 1793 |
| Total Applications | 433 |
| Issued Applications | 74 |
| Pending Applications | 96 |
| Abandoned Applications | 266 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7674689
[patent_doc_number] => 20040127429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Synthetic C-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases'
[patent_app_type] => new
[patent_app_number] => 10/462211
[patent_app_country] => US
[patent_app_date] => 2003-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19792
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20040127429.pdf
[firstpage_image] =>[orig_patent_app_number] => 10462211
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/462211 | Synthetic C-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases | Jun 12, 2003 | Issued |
Array
(
[id] => 5637416
[patent_doc_number] => 20060068389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Methods and compositions for inhibiting hiv replication'
[patent_app_type] => utility
[patent_app_number] => 10/515327
[patent_app_country] => US
[patent_app_date] => 2003-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5768
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20060068389.pdf
[firstpage_image] =>[orig_patent_app_number] => 10515327
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/515327 | Methods and compositions for inhibiting hiv replication | May 22, 2003 | Abandoned |
Array
(
[id] => 204262
[patent_doc_number] => 07629116
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-08
[patent_title] => 'Type I interferon-inducible proteins to detect viral infection'
[patent_app_type] => utility
[patent_app_number] => 10/441418
[patent_app_country] => US
[patent_app_date] => 2003-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3984
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/629/07629116.pdf
[firstpage_image] =>[orig_patent_app_number] => 10441418
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/441418 | Type I interferon-inducible proteins to detect viral infection | May 18, 2003 | Issued |
Array
(
[id] => 6829315
[patent_doc_number] => 20030180373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Method for viral inactivation of hydro-alcoholic solutions'
[patent_app_type] => new
[patent_app_number] => 10/240940
[patent_app_country] => US
[patent_app_date] => 2003-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3960
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20030180373.pdf
[firstpage_image] =>[orig_patent_app_number] => 10240940
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/240940 | Method for viral inactivation of hydro-alcoholic solutions | May 12, 2003 | Abandoned |
Array
(
[id] => 506288
[patent_doc_number] => 07202331
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-10
[patent_title] => 'Therapeutic anti-cytomegalovirus compounds'
[patent_app_type] => utility
[patent_app_number] => 10/434982
[patent_app_country] => US
[patent_app_date] => 2003-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19099
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/202/07202331.pdf
[firstpage_image] =>[orig_patent_app_number] => 10434982
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/434982 | Therapeutic anti-cytomegalovirus compounds | May 9, 2003 | Issued |
Array
(
[id] => 7394150
[patent_doc_number] => 20040038356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Step-wise process to recover or eliminate biological substances by flotation from underlayered colloidal medium'
[patent_app_type] => new
[patent_app_number] => 10/416440
[patent_app_country] => US
[patent_app_date] => 2003-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6732
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038356.pdf
[firstpage_image] =>[orig_patent_app_number] => 10416440
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/416440 | Step-wise process to recover or eliminate biological substances by flotation from underlayered colloidal medium | May 8, 2003 | Abandoned |
Array
(
[id] => 425269
[patent_doc_number] => 07271252
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-09-18
[patent_title] => 'Reagents for detecting efavirenz'
[patent_app_type] => utility
[patent_app_number] => 10/420196
[patent_app_country] => US
[patent_app_date] => 2003-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6525
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/271/07271252.pdf
[firstpage_image] =>[orig_patent_app_number] => 10420196
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/420196 | Reagents for detecting efavirenz | Apr 21, 2003 | Issued |
Array
(
[id] => 7392556
[patent_doc_number] => 20040038199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Phenotyping assay and reagents therefor'
[patent_app_type] => new
[patent_app_number] => 10/257607
[patent_app_country] => US
[patent_app_date] => 2003-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8228
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038199.pdf
[firstpage_image] =>[orig_patent_app_number] => 10257607
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/257607 | Phenotyping assay and reagents therefor | Apr 9, 2003 | Abandoned |
Array
(
[id] => 7219450
[patent_doc_number] => 20040072148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Simultaneous detection of HBV, HCV, and HIV in plasma samples using a multiplex capture assay'
[patent_app_type] => new
[patent_app_number] => 10/407897
[patent_app_country] => US
[patent_app_date] => 2003-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8948
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072148.pdf
[firstpage_image] =>[orig_patent_app_number] => 10407897
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/407897 | Simultaneous detection of HBV, HCV, and HIV in plasma samples using a multiplex capture assay | Apr 6, 2003 | Abandoned |
Array
(
[id] => 6730731
[patent_doc_number] => 20030186921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Recombinant gene expression vectors and methods for use of same to enhance the immune response of a host to an antigen'
[patent_app_type] => new
[patent_app_number] => 10/402100
[patent_app_country] => US
[patent_app_date] => 2003-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 15260
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20030186921.pdf
[firstpage_image] =>[orig_patent_app_number] => 10402100
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/402100 | Recombinant gene expression vectors and methods for use of same to enhance the immune response of a host to an antigen | Mar 25, 2003 | Abandoned |
Array
(
[id] => 6952129
[patent_doc_number] => 20050227223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Method of judging viral infection'
[patent_app_type] => utility
[patent_app_number] => 10/508678
[patent_app_country] => US
[patent_app_date] => 2003-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4150
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20050227223.pdf
[firstpage_image] =>[orig_patent_app_number] => 10508678
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/508678 | Method of judging viral infection | Mar 19, 2003 | Abandoned |
Array
(
[id] => 7020041
[patent_doc_number] => 20050222060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Compositions and methods to initiate or enhance antibody and major-histocompatibility class I or class II-restricted t cell responses by using immunomodulatory, non-coding rna motifs'
[patent_app_type] => utility
[patent_app_number] => 10/507942
[patent_app_country] => US
[patent_app_date] => 2003-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 19239
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222060.pdf
[firstpage_image] =>[orig_patent_app_number] => 10507942
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/507942 | Compositions and methods to initiate or enhance antibody and major-histocompatibility class I or class II-restricted t cell responses by using immunomodulatory, non-coding rna motifs | Mar 13, 2003 | Abandoned |
Array
(
[id] => 5727491
[patent_doc_number] => 20060058251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Methods for treating and preventing infectious disease'
[patent_app_type] => utility
[patent_app_number] => 10/382822
[patent_app_country] => US
[patent_app_date] => 2003-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 27288
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20060058251.pdf
[firstpage_image] =>[orig_patent_app_number] => 10382822
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/382822 | Methods for treating and preventing infectious disease | Mar 5, 2003 | Abandoned |
Array
(
[id] => 6835195
[patent_doc_number] => 20030162741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-28
[patent_title] => 'Oral DNA composition for hepatitis B virus chronic infection'
[patent_app_type] => new
[patent_app_number] => 10/375143
[patent_app_country] => US
[patent_app_date] => 2003-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 24360
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20030162741.pdf
[firstpage_image] =>[orig_patent_app_number] => 10375143
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/375143 | Oral DNA composition for hepatitis B virus chronic infection | Feb 27, 2003 | Abandoned |
Array
(
[id] => 7388963
[patent_doc_number] => 20040030118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-12
[patent_title] => 'Methods for regulating hematopoiesis using CpG-oligonucleotides'
[patent_app_type] => new
[patent_app_number] => 10/373381
[patent_app_country] => US
[patent_app_date] => 2003-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 26444
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0030/20040030118.pdf
[firstpage_image] =>[orig_patent_app_number] => 10373381
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/373381 | Methods for regulating hematopoiesis using CpG-oligonucleotides | Feb 23, 2003 | Abandoned |
Array
(
[id] => 5253302
[patent_doc_number] => 20070134758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Methods of inhibiting hiv-1 vpr activity and hiv-1 infectivity using atr or rad17 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/504249
[patent_app_country] => US
[patent_app_date] => 2003-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12033
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20070134758.pdf
[firstpage_image] =>[orig_patent_app_number] => 10504249
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/504249 | Methods of inhibiting hiv-1 vpr activity and hiv-1 infectivity using atr or rad17 inhibitors | Feb 12, 2003 | Abandoned |
Array
(
[id] => 7367435
[patent_doc_number] => 20040092468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Immunostimulatory oligonucleotides with modified bases and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/365678
[patent_app_country] => US
[patent_app_date] => 2003-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13766
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20040092468.pdf
[firstpage_image] =>[orig_patent_app_number] => 10365678
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/365678 | Immunostimulatory oligonucleotides with modified bases and methods of use thereof | Feb 9, 2003 | Abandoned |
Array
(
[id] => 6796903
[patent_doc_number] => 20030175777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Eleutherosides as adjuncts for vaccines and immune modulation'
[patent_app_type] => new
[patent_app_number] => 10/357913
[patent_app_country] => US
[patent_app_date] => 2003-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5012
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20030175777.pdf
[firstpage_image] =>[orig_patent_app_number] => 10357913
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/357913 | Eleutherosides as adjuncts for vaccines and immune modulation | Feb 3, 2003 | Abandoned |
Array
(
[id] => 6770400
[patent_doc_number] => 20030216340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences'
[patent_app_type] => new
[patent_app_number] => 10/357760
[patent_app_country] => US
[patent_app_date] => 2003-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14827
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20030216340.pdf
[firstpage_image] =>[orig_patent_app_number] => 10357760
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/357760 | Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences | Feb 2, 2003 | Issued |
Array
(
[id] => 6951800
[patent_doc_number] => 20050226894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Oral vaccination'
[patent_app_type] => utility
[patent_app_number] => 10/501402
[patent_app_country] => US
[patent_app_date] => 2003-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2719
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20050226894.pdf
[firstpage_image] =>[orig_patent_app_number] => 10501402
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/501402 | Oral vaccination | Jan 14, 2003 | Abandoned |